Molecular Cytogenetics Team
Team Leader: Dr Janet Shipley
Location: Male Urological Cancer Research Centre, Sutton
Section: Section of Molecular Carcinogenesis
Through identification and definition of genetic aberrations in tumours, particularly amplification events, we aim to identify gene products involved in the development of the following tumour types. These may represent clinically useful markers or therapeutic targets.
In the Section of Molecular Carcinogenesis
